• Register
  • Login

Iranian Journal of Pharmaceutical Sciences

  • Home
  • Journal Info
    • About the Journal
    • Aims and Scope
    • Editorial Team
    • Indexing & Abstracting
    • Privacy Statement
    • Contact us
  • Issues
    • Current
    • Archives
  • New Submissions
  • Author Guidelines
  • Policies & Process
    • Peer Review
    • Publication Ethics
    • Open Access Policy
    • Plagiarism
    • Retraction Policies
    • Archiving
  • Ethical Considration
Advanced Search
  1. Home
  2. Archives
  3. Vol. 13 No. 2 (2017): IJPS_Volume 13_Issue 2 (2017)
  4. Research/Original Articles

Vol. 13 No. 2 (2017)

April 2017

Toxicity of Atorvastatin on Isolated Brain Mitochondria Neurotoxicity of Atorvastatin

  • Sanaze Nasohi
  • Parvaneh Naserzadeh
  • Nafiseh Rahmanabadi
  • Banafsheh Saiid
  • Jalal Pourahmad

Iranian Journal of Pharmaceutical Sciences, Vol. 13 No. 2 (2017), 1 April 2017 , Page 1-12
https://doi.org/10.22037/ijps.v13.40685 Published: 2017-04-01

  • View Article
  • Download
  • Cite
  • References
  • Statastics
  • Share

Abstract

Background: Although the bio kinetics, metabolism and chemical toxicity of Atorvastatin are well known, until recently little attention was paid to the potential neurotoxic effect of Atorvastatin (Atv). Regarding the concrete evidences indicating Atv may reduce Coenzyme Q10 (CoQ10) levels through blockage of metalonate cycle, the present work aims to determine if Atorvastatin may provide toxic effects on brain mitochondria and whether its supplementation with two lipidicantioxidants, CoQ10 and Vit E may improve such outcomes.
Methods: to evaluate mitochondrial toxicity, male NMRI mice were first treated with Atorvastatin(bo; 20 and 60 mg/kg) every other day with or without supplementation with CoQ10 (200 mg/kg) or Vit E (40 u/kg). After a period of 4 weeks, the animals were euthanized and brain cortices were harvested ad subjected to mitochondria isolation procedure. ROS release, mitochondrial membrane potential (MMP) and cytochrome c release were performed to precisely address the probable mitochondrial injury.
Findings: Our data showed increased ROS formation, MMP collapse, mitochondrial swelling and cytochrome c release in Atorvastatin treated mice, suggesting that mitochondrial ROS formation and apoptosis signaling are likely involved in Atorvastatin neurotoxicity. Importantly according to the data from animals receiving either CoQ10 or Vit E, supplementation with these lipophilic antioxidants, remarkable reverted the corresponding Atorvastatin mitochondrial toxicity markers.
Concusion: Conclusively the present work addresses chronic Atorvastatin toxic effects on brain mitochondria and supports advantages of Vit E or CoQ10 supplementation. Whether such neurotoxic effect is correlated with CoQ10 depletion or if the improving effects of the due supplementation contribute toAtorvastatin receiving patients, needs more investigations.

Keywords:
  • Atorvastatin
  • Mitochondria
  • Apoptosis
  • brain
  • E vitamin
  • CoQ10
  • IJPS_Volume 13_Issue 2_Pages 1-12

How to Cite

Sanaze Nasohi, Parvaneh Naserzadeh, Nafiseh Rahmanabadi, Banafsheh Saiid, & Jalal Pourahmad. (2017). Toxicity of Atorvastatin on Isolated Brain Mitochondria: Neurotoxicity of Atorvastatin. Iranian Journal of Pharmaceutical Sciences, 13(2), 1–12. https://doi.org/10.22037/ijps.v13.40685
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

References

[1] Henshaw R, Jenkins BG, Schulz JB, Ferrante RJ, Kowall NW, Rosen BR, et al. Malonate produces striatal lesions by indirect NMDA receptor activation. Brain research(1994) 647(1):161-6.
[2] Shrim A, Garcia-Bournissen F, Maxwell C, Farine D, Koren G. Favorable pregnancy outcome following Trastuzumab (Herceptin®) use during pregnancy—Case report and updated literature review. Reproductive toxicology (2007) 23(4):611-3.
[3] Topol EJ. Intensive statin therapy-a sea change in cardiovascular prevention. New England Journal of Medicine. (2004) 350(15):1562-4.
[4] Frei B, Kim MC, Ames BN. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proceedings of the National Academy of Sciences. (1990) 87(12):4879-83.
[5] Favit A, Nicoletti F, Scapagnini U, Canonico PL. Ubiquinone protects cultured neurons against spontaneous and excitotoxin-induced degeneration. Journal of Cerebral Blood Flow & Metabolism (1992)12(4):638-45.
[6] Flora G, Gupta D, Tiwari A. Toxicity of lead: a review with recent updates. Interdiscip Toxicol (2012) 5(2):47-58.
[7] Flora S. Nutritional components modify metal absorption, toxic response and chelation therapy. Journal of nutritional & environmental medicine (2002): 12(1):53-67.
[8] Liebler DC. The role of metabolism in the antioxidant function of vitamin E. Critical reviews in toxicology (1993) 23(2):147-69.
[9] Zingg J-M. Vitamin E: an overview of major research directions. Molecular aspects of medicine. (2007) 28(5):400-22.
[10] El-Shenawy NS, AL-Harbi MS, Hamza RZ. Effect of vitamin E and selenium separately and in combination on biochemical, immunological and histological changes induced by sodium azide in male mice. Experimental and Toxicologic Pathology ( 2015) 67(1):65-76.
[11] Maaroufi K, Save E, Poucet B, Sakly M, Abdelmelek H, Had-Aissouni L. Oxidative stress and prevention of the adaptive response to chronic iron overload in the brain of young adult rats exposed to a 150 kilohertz electromagnetic field. Neuroscience (2011) 186:39-47.
[12] Kegeles LS, Humaran TJ, Mann JJ. In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy. Biological psychiatry (1998) 44(6):382-98.
[13] Ansari MA, Joshi G, Huang Q, Opii WO, Abdul HM, Sultana R, et al. In vivo administration of D609 leads to protection of subsequently isolated gerbil brain mitochondria subjected to in vitro oxidative stress induced by amyloid beta-peptide and other oxidative stressors: relevance to Alzheimer’s disease and other oxidative stress-related neurodegenerative disorders. Free Radical Biology and Medicine. (2006) 41(11):1694-703.
[14] Facecchia K, Fochesato L-A, Ray SD, Stohs SJ, Pandey S. Oxidative toxicity in neurodegenerative diseases: role of mitochondrial dysfunction and therapeutic strategies. Journal of toxicology (2011) 2011: 683728.
[15]Kidd PM. Neurodegeneration from mitochondrial insufficiency: nutrients, stem cells, growth factors, and prospects for brain rebuilding using integrative management. Alternative Medicine Review (2005)10(4):268.
[16] Barkur RR, Bairy LK. Assessment of oxidative stress in hippocampus, cerebellum and frontal cortex in rat pups exposed to lead (pb) during specific periods of initial brain development. Biological trace element research (2015)164 (2):212-8.
[17] Pourahmad J, Ghashang M, Ettehadi HA, Ghalandari R. A search for cellular and molecular mechanisms involved in depleted uranium (DU) toxicity. Environmental toxicology. 2006;21(4):349-54.
[18] Hodârnâu A, Dancea S, Bârzu O. Isolation of highly purified mitochondria from rat pancreas. The Journal of cell biology: (1973) 59(1):222-7.
[19] Odinokova IV, Shalbuyeva N, Gukovskaya AS, Mareninova OA. Isolation of pancreatic mitochondria and measurement of their functional parameters. The Pancreapedia: Exocrine Pancreas Knowledge Base, DOI: ( 2011)10.
[20] Zhao Y, Ye L, Liu H, Xia Q, Zhang Y, Yang X, et al. Vanadium compounds induced mitochondria permeability transition pore (PTP) opening related to oxidative stress. J Inorg Biochem (2010)104:371-8.
[21] Seydi E, Rajabi M, Salimi A, Pourahmad J. Involvement of mitochondrial-mediated caspase-3 activation and lysosomal labilization in acrylamide-induced liver toxicity. Toxicological & Environmental Chemistry (2015) 97(5):563-75.
[22] Zhao Y, Ye L, Liu H, Xia Q, Zhang Y, Yang X, et al. Vanadium compounds induced mitochondria permeability transition pore (PTP) opening related to oxidative stress. Journal of inorganic biochemistry
(2010)104(4):371-8.
[23] Henck J, Craft W, Black A, Colgin J, Anderson J. Pre-and postnatal toxicity of the HMG-CoA reductase inhibitor atorvastatin in rats. Toxicological sciences (1998) 41(1):88-99.
  • Abstract Viewed: 350 times
  • IJPS_Volume 13_Issue 2_Pages 1-12 Downloaded: 225 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Developed By

Open Journal Systems

Information

  • For Readers
  • For Authors
  • For Librarians
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

Creative Commons License
This journal (and its contents) is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Print ISSN: 1735-2444

Online ISSN: 2252-0457

Powered by OJSPlus